Browsing Category
Pharma Industry News
4764 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Pfizer’s danuglipron shows promising results in Phase 2b obesity trial
Pfizer Inc. (NYSE: PFE) has announced encouraging topline data from its Phase 2b clinical trial (NCT04707313) investigating danuglipron,…
December 3, 2023
FDA approves Ambio’s generic version of Forteo developed in collaboration with Apotex
Ambio, Inc., a leader in biotech innovation specializing in peptide drugs and complex generics, has announced that its…
December 3, 2023
PsychoGenics secures license for ENT1 inhibitor RO7117997 from Roche
PGI Drug Discovery LLC (PsychoGenics), recognized for its phenotypic drug discovery platform, has announced an exclusive license agreement…
December 3, 2023
Zydus Lifesciences announces FDA approval for heart failure drug, Ivabradine Tablets
Zydus Lifesciences Limited, a significant player in the pharmaceutical industry, has received final approval from the United States…
December 2, 2023
Lupin Limited launches Turqoz Tablets in US, aims to expand contraceptive market
Global pharmaceutical giant Lupin Limited has made a significant entry into the U.S. contraceptive market with the launch…
December 2, 2023
Venus Remedies expands global reach with market authorizations in Saudi Arabia and Philippines
Venus Remedies Limited, a prominent player in the global pharmaceutical industry, announced its latest achievement of receiving marketing…
December 2, 2023
Strides Pharma, Amneal Pharmaceuticals partner to launch Icosapent ethyl capsules
Strides Pharma Science Limited (“Strides”) has joined forces with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) to introduce Icosapent…
December 2, 2023
Syngene International finalizes Rs 617cr acquisition of biologics facility from Stelis Biopharma
Syngene International has announced the conclusion of its acquisition of a multi-modal biologics manufacturing facility, known as ‘Unit…
December 1, 2023
AbbVie to acquire ImmunoGen for $10.1bn to expand oncology portfolio
AbbVie Inc. and ImmunoGen Inc. have entered into a definitive agreement, marking a significant move in the pharmaceutical…
December 1, 2023
Perpetual Medicines secures $8m for peptide drug discovery platform
Perpetual Medicines, a frontrunner in computational peptide therapeutics, recently announced an impressive $8 million seed financing round, spearheaded…
December 1, 2023